Impact of Axillary Dissection on Staging and Regional Control in Breast Tumors = 10 mm: The DBCG experience

References

• Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 1992; 28A: 1415–8.
   Google Scholar
• Fentiman IS, Mansel RE. The axilla: not a no-go zone. Lancet 1991; 337: 221–3.
   PubMedGoogle Scholar
• Grabau DAa, Jensen M-B, Blichert-Toft M, et al. The impor-tance of surgery and accurate axillary staging for survival in breast cancer. Eur J Surg Oncol 1998; 24: 499–507.
   Google Scholar
• Epstein RJ. Routine or delayed axillary dissection for primary breast cancer? Eur J Cancer 1995; 31A: 1570–3.
   PubMedGoogle Scholar
• Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME. Axillary lymph node dissection: is it required in Tla breast cancer? J Am Coll Surg 1997; 184: 493–8.
   PubMedGoogle Scholar
• Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with Ti breast cancer. A multivariate analysis. Cancer 1994; 73: 350–3.
   Google Scholar
• Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with Ti breast carcinoma. Cancer 1997; 79: 1918–22.
   Google Scholar
• Haffty BG, Ward B, Pathare P, et al. Reappraisal of the role of axillary lymph node dissection in the conservative treat-ment of breast cancer. J Clin Oncol 1997; 15: 691–700.
   PubMedGoogle Scholar
• Greco M, Agresti R, Raselli R, Giovanazzi R, Veronesi U. Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases. Anticancer Res 1996; 16: 3913–7.
   Google Scholar
• Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colbum WJ, Gamagami P. Axillary lymph node dissection for Tla breast carcinoma. Is it indicated? Cancer 1994; 73: 664–7.
   Google Scholar
• Walls J, Boggis CR, Wilson M, et al. Treatment of the axilla in patients with screen-detected breast cancer. Br J Surg 1993; 80: 436–8.
   PubMed Web of Science ®Google Scholar
• Andersen KW, Mouridsen HT. Danish Breast Cancer Coop-erative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988; 27: 627–47.
   Google Scholar
• Scarf RW, Torloni H. Histological typing of breast tumours. Geneva: World Health Organization, 1968.
   Google Scholar
• Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359–77.
   PubMed Web of Science ®Google Scholar
• Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1995; 76: 1491–512.
   PubMed Web of Science ®Google Scholar
• Shetty MR. Axillary lymph node metastasis in carcinoma of the breast. J Am Coll Surg 1997; 184: 671–2.
   PubMedGoogle Scholar
• Maibenco DC, Weiss LK, Pawlish KS, Severson RK. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 1999; 85: 1530–6.
   PubMedGoogle Scholar
• Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (TINOMO) and stage II (TINIMO) breast carcinoma. J Clin Oncol 1989; 7: 355–66.
   Google Scholar
• Hellman S. Natural history of small breast cancers. J Clin Oncol 1994; 12: 2229–34.
   PubMed Web of Science ®Google Scholar
• Cady B. Is axillary lymph node dissection necessary in routine management of breast cancer? No. Important Adv Oncol 1996; 251–265.
   PubMedGoogle Scholar
• Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME. Axillary lymph node dissection: is it required in Tla breast cancer? J Am Coll Surg 1997; 184: 493–8.
   PubMedGoogle Scholar
• Saiz E, Toonkel R, Poppiti RJ, Robinson MJ. Infiltrating breast carcinoma smaller than 0.5 centimeters. Is lymph node dissection necessary? Cancer 1999; 85: 2206–11.
   Google Scholar
• White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of Tla and Tlb lesions. J Am Coll Surg 1996; 183: 575–82.
   PubMedGoogle Scholar
• Holland PA, Walls J, Boggis CRM, Knox F, Baildam AD, Bundred NJ. A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds. Br J Cancer 1996; 74: 1643–6.
   PubMedGoogle Scholar
• Sosa JA, Diener West M, Gusev Y, et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 1998; 5: 140–9.
   PubMedGoogle Scholar
• Ranaboldo CJ, Mitchel A, Royle GT, Theaker GM, Taylor I. Axillary nodal status in women with screen-detected breast cancer. Eur J Surg Oncol 1993; 19: 130–3.
   Google Scholar
• Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674–81.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who received adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Jensen M-B, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer pa-tients given adjuvant tamoxifen: Danish Breast Cancer Coop-erative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641–8.
   Google Scholar
• Fisher ER, Redmond C, Fisher B. Prognostic factors in NSABP studies of women with node-negative breast cancer. National Surgical Adjuvant Breast and Bowel Project. Monogr Natl Cancer Inst 1992; 151–8.
   Google Scholar
• Le MG, Arriagada R, de Vathaire F, et al. Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer 1990; 66: 2313–8.
   PubMed Web of Science ®Google Scholar
• Olivotto IA, Jackson JS, Mates D, et al. Prediction of axillary lymph node involvement of women with invasive breast car-cinoma: a multivariate analysis. Cancer 1998; 83: 948–55.
   PubMedGoogle Scholar
• Veronesi U. The sentinel node and breast cancer. Br J Surg 1999; 86: 1–2.
   PubMedGoogle Scholar